期刊文献+

血清胱抑素C对糖尿病肾病临床分期的价值 被引量:5

Clinical value of cystatin C in staging diabetic nephropathy
原文传递
导出
摘要 目的探讨胱抑素C(Cys-C)作为2型糖尿病(T2DM)肾病分期指标的应用价值。方法测定137例T2DM患者血肌酐(SCr)、Cys-C和24-h尿微量白蛋白排泄率(UAER)。运用MDRD公式计算肾小球滤过率(GFR)。将患者分为三组:GFR>120ml.min-1.1.73m-2为A组,GFR60~120ml.min-1.1.73m-2为B组,GFR<60ml.min-1.1.73m-2为C组。绘制散点图,比较三组Cys-C和UAER的数值及与GFR的相关性。结果C组SCr和24-hUAER高于A组[(102.41±10.72)μmol/Lvs.(42.73±3.99)μmol/L和(303.90±173.66)mgvs.(164.10±114.25)mg];A组Cys-C值明显低于B、C组[(0.47±0.21)mg/Lvs.(0.68±0.13)mg/L、(1.59±0.58)mg/L)]。UAER和Cys-C与GFR的相关系数分别为-0.132和-0.552(P<0.01)。ROC分析提示,Cys-C和UAER的曲线下面积(AUC)分别为0.885和0.605(P<0.05)。结论Cys-C能很好的反映T2DM肾病肾小球滤过功能异常,与临床分期的对应性、诊断特异性和灵敏性都优于UAER。 Objective To evaluate the clinical usefulness of serum cystatin C(Cys-C)in staging diabetic nephropathy.Methods Serum creatinine(SCr),Cys-C and urine albumin excretion rate(UAER) were detected in 137 patients with type 2 diabetes(T2DM).Glomelular filtration rate(GFR) was calculated with MDRD-GFR fomula,based on which the patients were divided into three groups of A(120 ml·min-1·1.73 m-2),B(60-120 ml·min-1·1.73 m-2) and C (60 ml·min-1·1.73 m-2).Correlation between Cys-C and UAER with GFR was analyzed.Results Cys-C and UAER were significantly higher in group C than those in group A /[(102.41±10.72) mol/L vs.(42.73±3.99) mol/L and (303.9±173.66) mg vs.(164.1±114.25) mg/].Cys-C was lower in group A than that in groups of B and C /[(0.47±0.21) mg/L vs.(0.68±0.13) mg/L and (1.59±0.58) mg/L/].The correlation coefficient was-0.132 for UAER and GFR and-0.552 for Cys-C and UAER (P0.01).Receiver operating characteristic curve(ROC) analysis showed the AUC of 0.885 for Cys-C and 0.605 for UAER.Conclusion The results indicate that Cys-C would be a good marker for the assessment of diabetic nephropathy in T2DM.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第6期642-645,共4页 Jiangsu Medical Journal
关键词 糖尿病肾病 肌酐 胱抑素C 尿微量白蛋白排泄率 Diabetic nephropathy Cystatin C Urine albumin excretion rate
  • 相关文献

参考文献8

  • 1KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease [J]. Am J Kidney Dis,2007,49(Suppl 2) :S12-S54. 被引量:1
  • 2吕文山,董砚虎,钱荣立.糖尿病的诊断和分型[J].中国糖尿病杂志,2000,8(1):60-61. 被引量:86
  • 3钱荣立主编,中华医学会糖尿病学会编..糖尿病临床指南[M].北京:北京医科大学、中国协和医科大学联合出版社,2000:318.
  • 4Kravaritou M, Thanopoulou A, Karamanos B, et al. Evidence that even "normal" albuminuria may denote ncipient GFR reduction in patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract,2009, 85(3):317-321. 被引量:1
  • 5刘建,杭永伦,侯静,李友芸.胱抑素与老年肌酐正常肾损害患者肾小球滤过率的相关性研究[J].中国实用内科杂志,2005,25(8):725-726. 被引量:14
  • 6Ogawa Y, Goto T, Tamasawa N, et al. Serum cystatin C in diabetic patients not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy[J]. Diabetes Res Clin Pract, ,2008,79 (2) :357-361. 被引量:1
  • 7Surendar J,Anuradha S,Ashley B,et al. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32) [J]. Metab Syndr Relat Disord, 2009,7(5) : 419-425. 被引量:1
  • 8Uslu S, Ere B, Alatas O, et al. Serum cystatin C and urinary enzyrnes as screening markers of renal dysfunction in diabetic patients[J]. J Nephrol, 2005,18(5) : 559-567. 被引量:1

二级参考文献5

共引文献98

同被引文献64

  • 1李珺,董吉祥.2型糖尿病患者糖尿病肾病危险因素分析[J].苏州大学学报(医学版),2005,25(2):272-274. 被引量:3
  • 2安新焕,宋滇平,刘华,王玉明,段勇,冯霞.IL-6基因启动子区-634C/G多态性与糖尿病肾病的相关性[J].中国糖尿病杂志,2007,15(5):289-291. 被引量:5
  • 3Fried LF, Duckworth W, Zhang JH, et al. Design of combination angiotensin receptor bIocker and angioten- sin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D)[J]. Clin J Am Soc Nephrol, 2009,4(2) : 361-368. 被引量:1
  • 4Bolignano D, Lacquaniti A, Coppolino G, et al. Neu- trophil gelatinase-associated lipocalin as an early bio- marker of nephropathy in diabetic patients[J]. Kidney Blood Press Res, 2009,32 (2) : 91-98. 被引量:1
  • 5Fehrman-Ekholml, Seeberger A, Bjorkj, et al. Serum cystatin C: a useful marker of kidney function in very old people[J]. Scand J Clin Lab Inwest,2009,69(5) :606. 被引量:1
  • 6Weomeg T LS,Pratesab,Do Amaral FB,et al. Gender does not in- fluence cystatin C concerntrations in healthy volunteers[J]. Clin Chem Lab Med,2010,48(3) :405. 被引量:1
  • 7Ogawa Y,Goto T,Tzmasawa N,et al. Serum cystatin C in diabet ic patients not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular e vents in patiants without nephnopathy[J]. Diabetes Res Clin Praet, 2008,79(2) : 357. 被引量:1
  • 8Surendar J, Anuradha S, Ashley B,et al. Cystatin C and Cystatin glomerular filtration rate as markers of early renal diaense in Asi- an Indian subjects with glucose intolerance (CURES-32)[J]. Metab Syndr Relat Disord,2009,7(5):419. 被引量:1
  • 9王吉彦.拉西地平联合缬沙坦对糖尿病高血压早期肾损害的疗效观察[J].医学信息,2012,24(7):507-508. 被引量:2
  • 10Guariguata L,Linnenkamp U,Beagley J,et al.Global estimates of the prevalence of hyperglycaemia in pregnancy[J].Diabetes Res Clin Pract,2014,103(2):176-185. 被引量:1

引证文献5

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部